The investigation of HLA microsatellites influence in predisposition to sarcoidosis among Croatians

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 28, Issue 1, 2011, Pages 18-26

  Grubić, Zorana ^a   Peros Golubicic T ^b   Sting K ^a   Zunec R ^a  

^a KBC Zagreb   (Croatia)

^b University Hospital for Lung Diseases Jordanovac   (Croatia)

Author keywords

Croatians; D6S1014; D6S273; HLA; Sarcoidosis; TNF

Indexed keywords

GENOMIC DNA; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; LYMPHOTOXIN; MICROSATELLITE DNA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BLOOD; CHRONIC DISEASE; CONTROLLED STUDY; CROATIA; DNA POLYMORPHISM; ELECTROPHORESIS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HAPLOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SARCOIDOSIS;

ADULT; AGED; ALLELES; CROATIA; DNA; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HLA ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; INCIDENCE; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES; SARCOIDOSIS; TIME FACTORS; YOUNG ADULT;

EID: 79960464311     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Baughman R, Lower E, du Bois RM. Sarcoidosis. Lancet 2003; 361: 1111-8.
2. Ziegenhagen MW, Müller-Quemheim J. The cytokine network in sarcoidosis and its clinical relevance. J Intern Med. 2003; 253: 18-30. (Pubitemid 36120994)
3. Martinerti M, Luisetti M, Cuccia M. HLA and sarcoidosis: new pathogenetic insights. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19: 83-95. (Pubitemid 34685906)
4. Sharma SK, Balamurugan A, Pandey RM. et al. Human Leukocyte Antigen-DR alleles influence the clinical course of pulmonary sarcoidosis in Asian Indians. Am J Respir Cell Mol Biol 2003; 29: 225-31. (Pubitemid 36936650)
5. Rossman MD, Thompson B, Frederick M, et al. HLA-DRB1*1101: A sigificant risk factor for sarcoidosis in Blacks and Whites. Am J Hum Genet 2003; 73: 720-35. (Pubitemid 37271878)
6. Schürmann M, Lympany PA, Reichel P, et al. Familial sarcoidosis is linked to the Major Histocompatibility Complex Region. Am J Respir Crit Care Med 2000; 162: 861-4.
7. Grubić Z, Źunec R, Peroś-Golubičić T, et al. HLA class I and class II frequencies in patients with sarcoidosis from Croatia: role of HLA-B8, -DRB1*0301, and DQB1*0201 haplotype in clinical variations of disease. Tissue Antigens 2007; 70: 301-6.
8. Swider C, Schnittger L, Bogunia-Kubik K, et al. TNF-alpha and HLA-DR genotyping as potential prognostic markers in pulmonary sarcoidosis. Eur Cytokine Netw 1999; 10: 143-6. (Pubitemid 29332769)
9. Seitzer U, Gerdes J, Müller-Ojiernheim. Evidence of disease phenotype associated haplotypes (DR.TNF) in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 279-83.
10. Somoskovi A, Zissel G, Seitzer U, Gerdes J, Schlaak M, Múller-Quernheim J. Polymorphisms at position 308 in the first intron of the TNF-beta genes and spontaneous and lipopolysaccharide-induced TNF-alpha release in sarcoidosis. Cytokine 1999; 11: 882-7. (Pubitemid 29537538)
11. Pandey JP, Frederick M, and ACCESS research group. TNF-α, ILβ, and Immunoglobulin (GM and KM) gene polymorphisms in sarcoidosis. Hum Immunology 2002; 63: 485-91.
12. Udalova IA, Nedosasova SA, Webb GC, Chaplin DD, Teretskaya RL. Higly informative typing the human TNF locus using six adjacent polymorphic markers. Genomics 1993; 16: 180-6. (Pubitemid 23123807)
13. Tsukamoto K, Ohta N, Shirai Y, Emi M. A highly polymorphic CA repeat marker at the human tumor necrosis factor alpha (TNFα) locus. J Hum Genet 1998; 43: 278-9. (Pubitemid 28566754)
14. Mrazek F, Holla LI, Hutyrova B, et al. Association of rumour necrosis factor-α, lymphotoxin-α and DRB1 gene polymorphisms with Löfgren's syndrome in Czech patients with sarcoidosis. Tissue Antigens 2004; 65: 163-71. (Pubitemid 40342447)
15. Labunski S, Posem G, Ludwig S, Kundt G, Bröcker EB, Kunz M. Tumour necrosis factor-alpha promoter polymorphism in erythema nodosum. Acta Derm Venereol 2001; 81: 18-21.
16. Grutters JC, Sato H, Pantelidis P, et al. Increased frequency of the uncommon tumor necrosis factor -857T allele in British and Dutch patients with sarcoidosis. Am J Respir Crit Care Med 2002; 165: 1119-24 (Pubitemid 34415821)
17. Takashige N, Naruse TK, Matsumori A, et al. Genetic polymorphism of tumor necrosis factor-β but not tumor necrosis factor loci (TNFA and TNFB) in cardiac sarcoidosis. Tissue Antigens 1999; 54: 185-90.
18. Haajer AH, Hutchunson IV. Influence of TNFα gene polymorphisms on TNFα production and disease. Hum Immunology 2001; 62: 1191-9.
19. Mattey DL, Hassell AB, Dawes PT, Ollier WER, Haajer A. Interaction between tumor necrosis factor microsatellite polymorphisms and the HLA-DRB1 shared epitope in rheumatoid arthritis. Arthritis & Rheumatism 1999; 42: 2698-702.
20. Törn C, Hillman M, Sanjeevi CB, Landin-Olsson M. Polymorphisms of TNF microsatellite marker a and HLA-DR-DQ. in diabetes mellitus-a study in 609 Swedish subjects. Hum Immunol. 2006; 67: 527-34. (Pubitemid 43994245)
21. Frank KH, Füssel M, Conrad K, et al. Different distribution of HLA class II and tumor necrosis factor alleles (TNF-308.2, TNFa2 microsatellite) in anti-topoisomerase I responders among scleroderma patients with and without exposure to quartz/metal dust. Arthritis Rheum 1998; 41: 1306-11. (Pubitemid 28313434)
22. Alenius GM, Friberg C, Nilsson S, Wahlström J, Dahlqvist SR, Samuelsson L. Analysis of 6 genetic loci for disease susceptibility in psoriatic arthritis. J Rheumatol 2004; 31: 2230-5. (Pubitemid 39453244)
23. Valdes AM, Wapelhorst B, Concannon P, Erlich HA, Thomson G, Noble JA. Extended DR3-D6S273-HLA-B haplotypes are associated with increased susceptibility to type 1 diabetes in US Caucasians. Tissue Antigens 2005; 65: 115-9. (Pubitemid 40179672)
24. Pascual M, Matarán L, Jones G, et al. HLA haplotypes and susceptibility to rheumatoid arthritis. More than class II genes. Scand J Rheumatol 2002; 31: 275-8. (Pubitemid 35252539)
25. Harjaek M, Margeti T, Kerhin-Brkljaci V, Martinez N, Grubi Z. HLA-B*27/HLA-B*07 in combination with D6S273-134 allele is associated with increased susceptibility to juvenile spondyloarthropathies. Clin Exp Rheumatol 2008; 26: 498-504. (Pubitemid 352005741)
26. van de Beek WJ. Roep BO, van der Slik AR, Giphart MJ, van Hilten BJ. Susceptibility loci for complex regional pain syndrome. Pain 2003; 103: 93-7. (Pubitemid 36579089)
27. International Psoriasis Genetics Consortium.The International Psoriasis Genetics Study: assessing linkage to 14 candidate susceptibility loci in a cohort of 942 affected sib pairs. Am J Hum Genet. 2003; 73: 430-7.
28. de Jong BA, Huizinga TW, Zanelli E, et al. Evidence for additional genetic risk indicators of relapse-onset MS within the HLA region. Neurology 2002; 59: 549-55. (Pubitemid 34919988)
29. Gourraud PA, Mano S, Barnetche T, Carrington M, Inoko H, Cambon-Thomsen A. Integration of microsatellites characteristics in the MHC region: a literature and sequence based analysis. Tissue Antigens 2004; 64: 543-55v
30. Grubić Z, Žunec R, Čečuk- Jeličić E, Kerhin-Brkljačić V, Kaštelan A. Polymorphism of HLA-A, B, DRB1, DQA1 and DQB1 haplotypes in the Croatian population. Eur J Immunogenet 2000; 27: 47-51.
31. Grubić Z, Štingl K, Žunec R, Car H, Čečuk-Jeličić E, Kerhin-Brkljačić V. Linkage disequilibrium between human leukocyte antigen-B and closely related microsatellites in the Croatian population. Tissue Antigens 2006; 89: 86-94.
32. Sato H, Gratters JC, Pantelidis P, et al. HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis. Am J Respir Cell Mol Biol 2002; 27: 406-12.
33. Bogunia-Kubik K, Tomeczko J, Suchnicki K, Lange A. HLA-DRB1'03, DRB1'11or DRB1'12 and their respective DRB3 specificities in clinical variants of sarcoidosis. Tissue Antigens 2001; 57: 87-90.
34. Spagnolo P, du Bois RM. Genetics of sarcoidosis. Clinicis in Dermatology 2007; 25: 242-9.
35. Grunewald J, Brynedal B, Darlington P, et al. Different HLA-DRB1 allele distributions in distinct clinical subgroups of sarcoidosis patients. Respiratory Research, 2010; 11: 25-31.
36. Rosman MD, Thompson B, Frederick M, et al. HLA-DRB1*1101: A significant risk factor for sarcoidosis in Blacks and Whites. Am J Hum Genet 2003; 73: 720-35. (Pubitemid 37271878)
37. Dubaniewicz A, Dubaniewicz-Wybieralska M, Moszkowska G, Sternau A, Dubaniewicz A. Comparative analysis of DR and DQ alleles occurrence in sarcoidosis and tuberculosis in the same ethnic group: preliminary study. Sarcoidosis Vasc Diffuse Lung Dis 2006; 23: 180-9. (Pubitemid 47596313)
38. Sharma SK, Balamurugan A, Pandey RM, Saha PK, Mehra NK. Human Leukocyte Antigen-DR alleles influence the clinical course of pulmonary sarcoidosis in Asian Indians. Am J Respir Cell Moll Biol 2003; 29: 225-31. (Pubitemid 36936650)
39. Rutherford RM, Bratsche MH, Kearns M , Bourke M, Stebens F, Gilmartin JJ. HLA-DR2 predicts susceptibility and disease chronicity in Irish sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 2004; 21: 191-4.
40. Voorter CEM, Drent M van den Berg-Loonen EM. Severe sarcoidosis is strongly associated with the haplotype HLADQB1*0602-DRB1*150101. Hum Immun 2005; 66: 826-35.
41. Grunewald J, Eklund A, Olerup O. Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients. Am J Respir Crit Care Med 2004; 169: 696-702. (Pubitemid 38338921)
42. Hino T, Nakamura H, Shibata Y, Abe S, Kato A, Tomoike H. Elevated of type II soluble tumor necrosis factor receptors in the bronchoalveolar lavage fluide of patients with sarcoidosis. Lung 1997; 175: 187-93 (Pubitemid 27147144)
43. Stuber P, Petersen M, Bokelmann F, Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-α concentrations and outcome of patients with severe sepsis. Cri Care Med 1996; 24: 381-4. (Pubitemid 26097828)